Found 28 results
Author Title Type [ Year(Asc)]
Filters: Author is Stablein, DM  [Clear All Filters]
2001
V. R. Dharnidharka, Ho, P. L., Stablein, D. M., Harmon, W. E., and Tejani, A., Initial immunosuppression with Mycophenolate or Tacrolimus is not associated with increased risk for post-transplant lymphoproliferative disorder: a North American Pediatric Cooperative Study (NAPRTCS) Report, 2001.
M. A. Baum, Stablein, D. M., Panzaarino, V. M., Tejani, A., Harmon, W. E., and , Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis, Kidney Int., vol. 59, pp. 328-33, 2001.
A. Al-Uzri, Stablein, D. M., and Cohn, R., Post-transplant diabetes mellitus in pediatric renal transplant recipients: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Transplantation, vol. 72, pp. 1020-4, 2001.
R. McDonald, Ho, P. L., Stablein, D. M., and Tejani, A., Rejection profile of recent pediatric renal transplant recipients compared with historical controls: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Am J Transplant, vol. 1, pp. 55-60, 2001.
C. S. Wong, Ho, P. L., Stablein, D. M., Alexander, S., Warady, B., Tejani, A., and Watkins, S. L., Risk Factors for Anemia During Erythropoietin Therapy Among Pediatric Dialysis Patients: A North American Pediatric Cooperative Study (NAPRTCS) Report, in ASN, Toronto, Canada, 2001.
V. R. Dharnidharka, Sullivan, E. K., Stablein, D. M., Tejani, A. H., and Harmon, W. E., Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Transplantation, vol. 71, pp. 1065-8, 2001.
2000
R. McDonald, Ho, P. L., Stablein, D. M., and Tejani, A., Acute rejection rate, time to first rejection and rejection reversals comparing the 1987-1989 pediatric renal transplant recipient cohort to the 1997-1999 cohort. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), 2000.
I. Elshihabi, Stablein, D. M., and Tejani, A., Emerging immunosuppressive profile of pediatric renal transplant recipients and its impact on graft survival, 2000.
I. Elshihabi, Stablein, D. M., and Tejani, A., Emerging immunosuppressive profile of pediatric renal transplant recipients and its impact on graft survival, 2000.
S. Schurman, Stablein, D. M., Garin, E. H., and Tejani, A., For the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Impact of puberty on renal function in children with chronic renal insufficiency (CRI), 2000.
R. Bures, Gaitan, A., Zhu, T., Graziosi, C., McGrath, K. M., Tartaglia, J., Caudrelier, P., R Habib, E., Klein, M., Lazzarin, A., Stablein, D. M., Deers, M., Corey, L., Greenberg, M. L., Schwartz, D. H., and Montefiore, D. C., Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus Type 1, AIDS Res HumRetroviruses, vol. 16, pp. 2019-35, 2000.
S. M. Bartosh and Stablein, D. M., Tacrolimus as primary immunosuppression for children receiving non-primary renal transplants: A report of the North American Pediatric Cooperative Study (NAPRTCS), 2000.